Depression and anxiety symptoms in young adults before and during the COVID-19 pandemic: evidence from a Canadian population-based cohort.
Anxiety
COVID-19
Depression
Mental health
Young adults
Journal
Annals of general psychiatry
ISSN: 1744-859X
Titre abrégé: Ann Gen Psychiatry
Pays: England
ID NLM: 101236515
Informations de publication
Date de publication:
08 Sep 2021
08 Sep 2021
Historique:
received:
01
07
2021
accepted:
11
08
2021
entrez:
9
9
2021
pubmed:
10
9
2021
medline:
10
9
2021
Statut:
epublish
Résumé
Concerns have been raised that the COVID-19 pandemic could increase risk for adverse mental health outcomes, especially in young adults, a vulnerable age group. We investigated changes in depression and anxiety symptoms (overall and severe) from before to during the pandemic, as well as whether these changes are linked to COVID-19-related stressors and pre-existing vulnerabilities in young adults followed in the context of a population-based cohort. Participants (n = 1039) from the Quebec Longitudinal Study of Child Development reported on their depression (Centre for Epidemiological Studies Depression Scale, short form) and anxiety (General Anxiety Disorder-7 Scale) symptoms and completed a COVID-19 questionnaire during the first wave of the COVID-19 pandemic in the summer of 2020 (age 22 years). Assessments at age 20 (2018) were used to estimate pre-pandemic depression and anxiety symptom severity. While mean levels of depression and anxiety symptoms did not change from before to during the first wave of the COVID-19 pandemic (e.g., the mean of depressive symptoms was 9.30 in 2018 and 9.59 in 2020), we observed a slight increase in rates of severe depression (scores ≥ 21) from before (6.1%) to during (8.2%) the pandemic. Most COVID-19-related variables (e.g., loss of education/occupation, frequent news-seeking) - except living alone - and most pre-existing vulnerabilities (e.g., low SES, low social support) were not associated with changes in depression or anxiety symptoms. However, results varied as a function of pre-pandemic levels of depression and anxiety: depression and anxiety symptoms increased among adults with the lowest levels of symptoms before the pandemic, while they decreased among those with the highest levels of symptoms, possibly reflecting a regression to the mean. Depression and anxiety symptoms in young adults from Québec in Summer 2020 were mostly comparable to symptoms reported in 2018. Most COVID-19-related stressors and pre-existing vulnerabilities were not associated with changes in symptoms, except living alone and pre-existing symptoms of depression and anxiety. However, the increased rate of severe depression warrants further investigation.
Sections du résumé
BACKGROUND
BACKGROUND
Concerns have been raised that the COVID-19 pandemic could increase risk for adverse mental health outcomes, especially in young adults, a vulnerable age group. We investigated changes in depression and anxiety symptoms (overall and severe) from before to during the pandemic, as well as whether these changes are linked to COVID-19-related stressors and pre-existing vulnerabilities in young adults followed in the context of a population-based cohort.
METHOD
METHODS
Participants (n = 1039) from the Quebec Longitudinal Study of Child Development reported on their depression (Centre for Epidemiological Studies Depression Scale, short form) and anxiety (General Anxiety Disorder-7 Scale) symptoms and completed a COVID-19 questionnaire during the first wave of the COVID-19 pandemic in the summer of 2020 (age 22 years). Assessments at age 20 (2018) were used to estimate pre-pandemic depression and anxiety symptom severity.
RESULTS
RESULTS
While mean levels of depression and anxiety symptoms did not change from before to during the first wave of the COVID-19 pandemic (e.g., the mean of depressive symptoms was 9.30 in 2018 and 9.59 in 2020), we observed a slight increase in rates of severe depression (scores ≥ 21) from before (6.1%) to during (8.2%) the pandemic. Most COVID-19-related variables (e.g., loss of education/occupation, frequent news-seeking) - except living alone - and most pre-existing vulnerabilities (e.g., low SES, low social support) were not associated with changes in depression or anxiety symptoms. However, results varied as a function of pre-pandemic levels of depression and anxiety: depression and anxiety symptoms increased among adults with the lowest levels of symptoms before the pandemic, while they decreased among those with the highest levels of symptoms, possibly reflecting a regression to the mean.
CONCLUSIONS
CONCLUSIONS
Depression and anxiety symptoms in young adults from Québec in Summer 2020 were mostly comparable to symptoms reported in 2018. Most COVID-19-related stressors and pre-existing vulnerabilities were not associated with changes in symptoms, except living alone and pre-existing symptoms of depression and anxiety. However, the increased rate of severe depression warrants further investigation.
Identifiants
pubmed: 34496901
doi: 10.1186/s12991-021-00362-2
pii: 10.1186/s12991-021-00362-2
pmc: PMC8424412
doi:
Types de publication
Journal Article
Langues
eng
Pagination
42Informations de copyright
© 2021. The Author(s).
Références
Int J Environ Res Public Health. 2020 May 02;17(9):
pubmed: 32370116
JAMA Netw Open. 2020 Dec 1;3(12):e2027491
pubmed: 33275154
Psychol Med. 2015 Aug;45(11):2427-36
pubmed: 25804325
Psychol Med. 2020 Jun 23;:1-10
pubmed: 32571438
Lancet Psychiatry. 2020 Jun;7(6):547-560
pubmed: 32304649
Pediatrics. 2016 Apr;137(4):
pubmed: 26962239
Lancet Psychiatry. 2021 Feb;8(2):141-149
pubmed: 33308420
Pediatrics. 2016 Dec;138(6):
pubmed: 27940701
Aust N Z J Psychiatry. 2017 Aug;51(8):774-787
pubmed: 28565925
Psychiatry Res. 2020 Nov;293:113462
pubmed: 32987222
Am J Public Health. 2015 Nov;105(11):2322-7
pubmed: 26378840
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Soc Sci Med. 2021 Jan;269:113557
pubmed: 33308909
Am J Psychiatry. 2020 Jul 1;177(7):574-575
pubmed: 32375540
Can J Psychiatry. 2021 Jan 19;:706743720986786
pubmed: 33464115
Int J Ment Health Syst. 2019 Apr 8;13:23
pubmed: 30996733
Clin Med (Lond). 2015 Apr;15(2):151-4
pubmed: 25824067
Soc Psychiatry Psychiatr Epidemiol. 2021 May;56(5):883-894
pubmed: 33185737
Gen Psychiatr. 2020 Mar 6;33(2):e100213
pubmed: 32215365
Lancet Psychiatry. 2021 Feb;8(2):121-129
pubmed: 33306975
Int J Environ Res Public Health. 2020 Jun 02;17(11):
pubmed: 32498267
Int J Environ Res Public Health. 2020 Nov 20;17(22):
pubmed: 33233513
J Learn Disabil. 2009 Jan-Feb;42(1):24-40
pubmed: 19103798
J Am Acad Child Adolesc Psychiatry. 2021 Jan;60(1):134-141.e2
pubmed: 33091568
JAMA Netw Open. 2020 Mar 2;3(3):e203976
pubmed: 32202646
J Child Psychol Psychiatry. 2016 Feb;57(2):196-203
pubmed: 26791344
Brain Behav Immun. 2020 Jul;87:172-176
pubmed: 32405150
J Psychiatr Res. 2021 Apr;136:603-609
pubmed: 33138985
Int J Soc Psychiatry. 2020 Aug;66(5):504-511
pubmed: 32380879
Chronic Dis Can. 2005 Spring-Summer;26(2-3):65-72
pubmed: 16251012
JAMA. 2020 Jul 7;324(1):93-94
pubmed: 32492088
N Engl J Med. 2020 Aug 6;383(6):510-512
pubmed: 32283003
Lancet Psychiatry. 2020 Jul;7(7):567-568
pubmed: 32502467
JAMA Psychiatry. 2021 Jan 1;78(1):9-10
pubmed: 32579160
Int J Environ Res Public Health. 2020 May 31;17(11):
pubmed: 32486380
Sante Ment Que. 2013 Spring;38(1):297-318
pubmed: 24337002
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jul 13;109:110236
pubmed: 33373680